Interactive Transcript
0:00
Airway nodules on lung cancer screening CT are not very
0:04
common, but when they occur, it's important for us
0:06
to recognize when they become actionable
0:09
and when they simply represent evidence
0:11
of underlying lung disease such as asthma
0:14
or chronic bronchitis, different forms
0:15
of chronic obstructive pulmonary disease.
0:18
We're gonna talk about the lung rads categories
0:21
for airway nodules, which was first introduced
0:23
with Lung RADS 2022,
0:25
and the follow-up recommendations that come
0:27
with that categorization.
0:29
Another important feature to consider
0:31
among airway nodules are things we're used
0:33
to seeing every day on cha cts,
0:35
which are secretions in the airway.
0:38
When can you cause something secretions
0:40
or moid impaction evidence of small area disease
0:44
or when does it become an actionable nodule?
0:47
So we'll look at some cases, about half a percent
0:50
of lung cancer screening CT exams will have
0:53
an endo bronchial lesion.
0:55
And by this I don't mean things
0:57
that we consider secretions when we look at them.
1:00
Over 96% of these do resolve on followup imaging,
1:04
and most of them that don't are benign.
1:06
But within this group, there are cancers
1:09
in the Dutch Belgian Nelson trial for lung cancer screening.
1:13
22% of cancers missed on the initial screening
1:16
or endobronchial.
1:18
And by this I mean primarily segmental lobar
1:21
and rarely distal trachea.
1:23
The category for lung rats of
1:25
where endobronchial nodules go in the schema are based on
1:29
location morphology, the number of them,
1:32
and if they persist on followup cts.
1:36
Category zero, meaning we don't score it in lung rads,
1:39
are the typical findings of endobronchial secretions.
1:42
They're often linear.
1:44
If they're lumpy, they have little bits
1:45
of air mix within them, they look sort of frothy
1:48
or they may be branching in tubular.
1:51
We start to get into the lung rads numbering of two four A
1:54
and four B with category two, an endobronchial nodule
1:58
that is a subsegmental airway nodule
2:01
or air within an airway nodule in the absence
2:04
of a soft tissue component
2:05
or mean attenuation less than 21 household units.
2:09
This was the best way for us to describe things
2:11
that are probably secretions.
2:13
Therefore lung rads two negative screens,
2:16
but we will want to follow them on the next annual screening
2:19
CT category four A.
2:21
This is where we get concerned
2:23
and want to do interval follow-up is when we have a
2:26
segmental or proximal airway nodule without the benign
2:29
features of low density or air within them.
2:33
And for these, we recommend a three month low dose ct.
2:36
Typical of the four. A recommendation category
2:39
when we get most concerned are the nodules
2:41
that are in the four B category.
2:43
These are endobronchial nodules that are in segmental
2:45
or larger airways that are persisting on follow-up cts,
2:50
or grow over time.
2:52
These should be referred
2:53
for clinical evaluation and bronchoscopy.
2:56
One of the questions I commonly get about endobronchial
2:59
Nodules, is there anything we can do to prevent some
3:02
of these nodules from even showing up on our lung cancer
3:04
screening cts?
3:06
What I usually recommend is that our imaging technologists
3:09
who are acquiring the CT images, when the patient comes
3:12
for their exam, ask the patient to take several deep,
3:15
big coughs before they lay down on a scatter table.
3:19
This can help them clear small areas of secretions
3:22
that we won't have to see on the CT examinations
3:24
because of this simple intervention.
3:27
So a few good coughs
3:28
before laying down on the CT table can prevent you even
3:31
having some of these on your images to look at.